Scarcity drives pharmacy substitution

Community pharmacists are now able to substitute Actemra formulations without prior prescriber approval, due to serious shortages Two tocilizumab (Actemra) formulations are now effectively interchangeable at the pharmacy level after the TGA declared them to be “scarce and substitutable medicines”: ACTEMRA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled syringe (AUST R: 234034) ACTEMRA

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Green light for Moderna
Next $16 for jab ‘won't even cover the wages.’